Clicky

MediWound Ltd.(MDWD)

Description: MediWound Ltd., an integrated biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the treatment of severe burns, chronic and other hard-to-heal wounds, and connective tissue disorders. Its lead product candidate is EscharEx, which is in Phase II clinical trials for the debridement of chronic and other hard-to-heal wounds. The company is also developing NexoBrid for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel.


Keywords: Medicine Biopharmaceutical Clinical Medicine Wound Burns Acute Pain Medical Emergencies Connective Tissue Necrosis Tissue Debridement Yavne

Home Page: www.mediwound.com

MDWD Technical Analysis

42 Hayarkon Street
Yavne, 8122745
Israel
Phone: 972 7 797 14100


Officers

Name Title
Prof. Lior Rosenberg M.D. Co-Founder & Medical Director
Mr. Boaz Gur-Lavie CPA, M.B.A. Chief Financial Officer
Mr. Yaron Meyer Adv. Exec. VP, Gen. Counsel & Corp. Sec.
Dr. Ety Klinger Chief R&D Officer
Mr. Ofer Gonen B.Sc. Chief Exec. Officer
Mr. Tzvi Palash B.Sc., M.Sc. Chief Operating Officer
Mr. Stephen T. Wills CPA, CPA, MST Exec. Director
Dr. Robert J. Snyder CWS, D.P.M., F.A.C.F.A.S., FFPM, M.B.A., M.Sc. Chief Medical Officer

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 31.7321
Price-to-Sales TTM: 2.4803
IPO Date: 2014-03-20
Fiscal Year End: December
Full Time Employees: 77
Back to stocks